Joincare Pharmaceutical Group Industry Co.,Ltd. (600380.SS)
CNY 11.32
(-0.18%)
CNY 11.32
(-0.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 16.64 Billion | 17.14 Billion | 15.9 Billion | 13.52 Billion | 11.98 Billion | 11.2 Billion |
| Cost of Revenue | 6.85 Billion | 6.25 Billion | 5.71 Billion | 4.87 Billion | 4.27 Billion | 4.21 Billion |
| Gross Profit | 9.79 Billion | 10.89 Billion | 10.18 Billion | 8.64 Billion | 7.7 Billion | 6.98 Billion |
| Operating Expenses | 6.84 Billion | 7.59 Billion | 7.29 Billion | 5.87 Billion | 5.68 Billion | 5.44 Billion |
| Selling, General and Administrative Expenses | 5.24 Billion | 5.17 Billion | 5.32 Billion | 4.3 Billion | 4.29 Billion | 4.3 Billion |
| Research and Development Expenses | 1.66 Billion | 1.74 Billion | 1.39 Billion | 1.07 Billion | 905.59 Million | 708.44 Million |
| Other Expenses | -288.38 Million | 682.06 Million | 581.06 Million | 501.98 Million | 479.49 Million | 167.54 Million |
| Cost and Expenses | 13.13 Billion | 13.84 Billion | 13.01 Billion | 10.75 Billion | 9.95 Billion | 9.66 Billion |
| Operating Income | 3.5 Billion | 3.47 Billion | 2.98 Billion | 2.97 Billion | 2.18 Billion | 1.59 Billion |
| Interest Expense | 154.66 Million | 139.01 Million | 90.27 Million | 35.68 Million | 63.09 Million | 145.91 Million |
| Income Tax Expense | 614.53 Million | 562 Million | 339.48 Million | 371.69 Million | 328.08 Million | 273.4 Million |
| Earnings before Tax | 3.46 Billion | 3.45 Billion | 2.95 Billion | 2.95 Billion | 2.17 Billion | 1.73 Billion |
| Net Income | 1.44 Billion | 2.89 Billion | 2.61 Billion | 2.57 Billion | 1.85 Billion | 699.41 Million |
| Earnings Per Share Basic | 0.76 | 1.53 | 1.35 | 1.33 | 0.95 | 0.43 |
| Earnings Per Share Diluted | 0.76 | 1.53 | 1.35 | 1.32 | 0.95 | 0.43 |
| Weighted Average Shares Outstanding | 1.9 Billion | 1.89 Billion | 1.93 Billion | 1.93 Billion | 1.93 Billion | 1.63 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.9 Billion | 1.89 Billion | 1.93 Billion | 1.95 Billion | 1.94 Billion | 1.63 Billion |
| Gross Margin | 0.59 | 0.64 | 0.64 | 0.64 | 0.64 | 0.62 |
| EBIT Margin | 0.30 | 0.27 | 0.23 | 0.27 | 0.24 | 0.22 |
| Profit Margin | 0.09 | 0.17 | 0.16 | 0.19 | 0.15 | 0.06 |
| EBITDA | 5.01 Billion | 4.73 Billion | 3.7 Billion | 3.56 Billion | 2.8 Billion | 2.44 Billion |
| Earnings Before Tax Margin | 0.21 | 0.20 | 0.19 | 0.22 | 0.18 | 0.14 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 3.66 Billion | 3.84 Billion | 4.29 Billion | 3.94 Billion | 16.44 Billion | 3.93 Billion |
| Cost of Revenue | 1.37 Billion | 1.5 Billion | 1.58 Billion | 1.57 Billion | 6.85 Billion | 1.56 Billion |
| Gross Profit | 2.29 Billion | 2.34 Billion | 2.7 Billion | 2.36 Billion | 9.59 Billion | 2.36 Billion |
| Operating Expenses | 1.42 Billion | 1.52 Billion | 1.74 Billion | 1.79 Billion | 6.77 Billion | 1.74 Billion |
| Selling, General and Administrative Expenses | 1.84 Billion | 1.14 Billion | 1.36 Billion | 1.21 Billion | - | 1.58 Billion |
| Research and Development Expenses | 321.64 Million | 296.34 Million | 377.1 Million | 375.57 Million | - | 446.43 Million |
| Other Expenses | -740.75 Million | -78.1 Million | -4.07 Million | -203.92 Million | -288.38 Million | 9.03 Million |
| Cost and Expenses | 2.8 Billion | 3.02 Billion | 3.33 Billion | 3.37 Billion | 13.63 Billion | 3.3 Billion |
| Operating Income | 845.46 Million | 817.68 Million | 959.37 Million | 570.21 Million | 2.81 Billion | 738.23 Million |
| Interest Expense | 22.51 Million | 38.72 Million | 33.73 Million | 40.3 Million | 146.72 Million | 36.36 Million |
| Income Tax Expense | 99.8 Million | 124.39 Million | 161.42 Million | 180.71 Million | 614.53 Million | 109.16 Million |
| Earnings before Tax | 837.28 Million | 889.9 Million | 1.06 Billion | 772.01 Million | 3.39 Billion | 726.38 Million |
| Net Income | 335.13 Million | 336.62 Million | 439.79 Million | 359.13 Million | 1.44 Billion | 268.21 Million |
| Earnings Per Share Basic | 0.18 | 0.18 | 0.24 | 0.19 | - | 0.14 |
| Earnings Per Share Diluted | 0.18 | 0.18 | 0.24 | 0.19 | - | 0.14 |
| Weighted Average Shares Outstanding | 1.87 Billion | 1.86 Billion | 1.86 Billion | 1.86 Billion | 1.86 Billion | 1.89 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.87 Billion | 1.87 Billion | 1.86 Billion | 1.86 Billion | 1.9 Billion | 1.89 Billion |
| Gross Margin | 0.63 | 0.61 | 0.63 | 0.60 | 0.58 | 0.60 |
| EBIT Margin | 0.23 | 0.27 | 0.26 | 0.21 | - | 0.22 |
| Profit Margin | 0.09 | 0.09 | 0.10 | 0.09 | 0.09 | 0.07 |
| EBITDA | 859.8 Million | 1.05 Billion | 1.12 Billion | 819.73 Million | - | 863.98 Million |
| Earnings Before Tax Margin | 0.23 | 0.21 | 0.22 | 0.14 | 0.17 | 0.19 |
VEII
WTFC
AMS
GISSAA
ICO
3388